Rockwell Medical (RMTI) Other Non Operating Income (2017 - 2026)
Rockwell Medical (RMTI) posted Other Non Operating Income of -$125000.0 for Q1 2026, up 19.87% on a QoQ basis from -$156000.0 in Q4 2025, and up 19.35% year-over-year from -$104729.7 in Q1 2025.
Rockwell Medical (RMTI) Other Non Operating Income (2017 - 2026) Analysis & Trends
Rockwell Medical's Other Non Operating Income history runs 10 years deep, the most recent figure standing at -$125000.0 for Q1 2026.
- Quarterly Other Non Operating Income rose 19.35% year-over-year to -$125000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$593000.0 (up 29.07% YoY) and the FY2025 annual result came in at -$623000.0, up 42.74% from the prior year.
- Other Non Operating Income was -$125000.0 for Q1 2026 at Rockwell Medical, up from -$156000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at -$125000.0 in Q1 2026 and bottomed at -$965000.0 in Q4 2023.
- A 5-year average of -$323764.7 and a median of -$272000.0 in 2024 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2023 — Other Non Operating Income tumbled 143.69% — and 2024, when it surged 75.44%.
- Rockwell Medical's Other Non Operating Income stood at -$396000.0 in 2022, then tumbled by 143.69% to -$965000.0 in 2023, then jumped by 75.44% to -$237000.0 in 2024, then surged by 34.18% to -$156000.0 in 2025, then increased by 19.87% to -$125000.0 in 2026.
- Business Quant data shows RMTI's Other Non Operating Income at -$125000.0 in Q1 2026, -$156000.0 in Q4 2025, and -$169000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Rockwell Medical | 25.77 Mn | 1.88 Mn | 2.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -125,000.00 |
| Dec 31, 2025 | -156,000.00 |
| Sep 30, 2025 | -169,000.00 |
| Jun 30, 2025 | -143,000.00 |
| Mar 31, 2025 | -155,000.00 |
| Dec 31, 2024 | -237,000.00 |
| Sep 30, 2024 | -272,000.00 |
| Jun 30, 2024 | -172,000.00 |
| Mar 31, 2024 | -407,000.00 |
| Dec 31, 2023 | -965,000.00 |
| Sep 30, 2023 | -135,000.00 |
| Jun 30, 2023 | -346,000.00 |
| Mar 31, 2023 | -323,000.00 |
| Dec 31, 2022 | -396,000.00 |
| Sep 30, 2022 | -482,000.00 |
| Jun 30, 2022 | -485,000.00 |
| Mar 31, 2022 | -536,000.00 |
| Dec 31, 2021 | -582,000.00 |
| Sep 30, 2021 | -609,000.00 |
| Jun 30, 2021 | -577,000.00 |